Maxim Group Upgrades Pluristem Therapeutics (PSTI) to Buy
Tweet Send to a Friend
Maxim Group upgraded Pluristem Therapeutics (NASDAQ: PSTI) from Hold to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
